Cargando...
Real-World Evidence for Chronic Lymphocytic Leukemia in the Era of Targeted Therapies
The landscape of chronic lymphocytic leukemia (CLL) has transformed in the era of small molecule inhibitor targeted therapies. While randomized controlled trials (RCTs) remain the gold-standard in evaluating new therapies, they are often unable to keep pace with the clinical questions that arise dur...
Guardado en:
| Publicado en: | Cancer J |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7427105/ https://ncbi.nlm.nih.gov/pubmed/31764126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000407 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|